Increased Effector Memory Insulin-Specific CD4+ T Cells Correlate With Insulin Autoantibodies in Patients With Recent-Onset Type 1 Diabetes
Open Access
- 25 August 2017
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 66 (12) , 3051-3060
Abstract
Type 1 diabetes (T1D) results from T cell–mediated destruction of insulin-producing β-cells. Insulin represents a key self-antigen in disease pathogenesis, as recent studies identified proinsulin-responding T cells from inflamed pancreatic islets of organ donors with recent-onset T1D. These cells respond to an insulin B-chain (InsB) epitope presented by the HLA-DQ8 molecule associated with high T1D risk. Understanding insulin-specific T-cell frequency and phenotype in peripheral blood is now critical. We constructed fluorescent InsB10–23:DQ8 tetramers, stained peripheral blood lymphocytes directly ex vivo, and show DQ8+ patients with T1D have increased tetramer+ CD4+ T cells compared with HLA-matched control subjects without diabetes. Patients with a shorter disease duration had higher frequencies of insulin-reactive CD4+ T cells, with most of these cells being antigen experienced. We also demonstrate that the number of insulin tetramer+ effector memory cells is directly correlated with insulin antibody titers, suggesting insulin-specific T- and B-cell interactions. Notably, one of four control subjects with tetramer+ cells was a first-degree relative who had insulin-specific cells with an effector memory phenotype, potentially representing an early marker of T-cell autoimmunity. Our results suggest that studying InsB10–23:DQ8 reactive T-cell frequency and phenotype may provide a biomarker of disease activity in patients with T1D and those at risk.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-108868)
- National Institute of Allergy and Infectious Diseases (P01-AI-35296, R01-AI-106791, U24-AI-118635)
- JDRF (3-2014-215, 17-2014-3)
This publication has 54 references indexed in Scilit:
- Predictors of slow progression to diabetes in children with multiple islet autoantibodiesJournal of Autoimmunity, 2016
- Genetic risk factors for type 1 diabetesThe Lancet, 2016
- Monoclonal antibody blocking the recognition of an insulin peptide–MHC complex modulates type 1 diabetesProceedings of the National Academy of Sciences, 2014
- Antigen Targets of Type 1 Diabetes AutoimmunityCold Spring Harbor Perspectives in Medicine, 2012
- Diabetogenic T cells recognize insulin bound to IAg7in an unexpected, weakly binding registerProceedings of the National Academy of Sciences, 2010
- Changes in autoreactive T cell avidity during type 1 diabetes developmentClinical Immunology, 2009
- Natural peptides selected by diabetogenic DQ8 and murine I-Ag7 molecules show common sequence specificityJournal of Clinical Investigation, 2005
- Prime role for an insulin epitope in the development of type 1 diabetes in NOD miceNature, 2005
- THE NOD MOUSE: A Model of Immune DysregulationAnnual Review of Immunology, 2005
- Precursor frequencies of T-cells reactive to insulin in recent onset type 1 diabetes mellitusJournal of Autoimmunity, 2004